342 related articles for article (PubMed ID: 35677107)
1. Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases.
Jia MQ; Guan CX; Tao JH; Zhou Y
Oxid Med Cell Longev; 2022; 2022():5042762. PubMed ID: 35677107
[TBL] [Abstract][Full Text] [Related]
2. The endocrine FGFs axis: A systemic anti-fibrotic response that could prevent pulmonary fibrogenesis?
Ghanem M; Archer G; Crestani B; Mailleux AA
Pharmacol Ther; 2024 Jul; 259():108669. PubMed ID: 38795981
[TBL] [Abstract][Full Text] [Related]
3. [Fibroblast growth factor (FGF) endocrines and pulmonary fibrogenesis].
Ghanem M; Mailleux A; Crestani B
Rev Mal Respir; 2023 Mar; 40(3):239-242. PubMed ID: 36828676
[TBL] [Abstract][Full Text] [Related]
4. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways.
Lee KJ; Jang YO; Cha SK; Kim MY; Park KS; Eom YW; Baik SK
Gut Liver; 2018 Jul; 12(4):449-456. PubMed ID: 29699061
[TBL] [Abstract][Full Text] [Related]
6. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
[TBL] [Abstract][Full Text] [Related]
7. The Saga of Endocrine FGFs.
Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
[TBL] [Abstract][Full Text] [Related]
8. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
[TBL] [Abstract][Full Text] [Related]
9. FGF19 subfamily members: FGF19 and FGF21.
Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
[TBL] [Abstract][Full Text] [Related]
10. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
11. The structural biology of the FGF19 subfamily.
Beenken A; Mohammadi M
Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
[TBL] [Abstract][Full Text] [Related]
12. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
[TBL] [Abstract][Full Text] [Related]
13. An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity.
Babaknejad N; Nayeri H; Hemmati R; Bahrami S; Esmaillzadeh A
Horm Metab Res; 2018 Jun; 50(6):441-452. PubMed ID: 29883971
[TBL] [Abstract][Full Text] [Related]
14. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
[TBL] [Abstract][Full Text] [Related]
15. Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.
Feng S; Dakhova O; Creighton CJ; Ittmann M
Cancer Res; 2013 Apr; 73(8):2551-62. PubMed ID: 23440425
[TBL] [Abstract][Full Text] [Related]
16. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
Kurosu H; Kuro-O M
Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
[TBL] [Abstract][Full Text] [Related]
17. The Role of Fibroblast Growth Factor 19 Subfamily in Different Populations Suffering From Osteoporosis.
Yu X; Xia Y; Jia J; Yuan G
Front Endocrinol (Lausanne); 2022; 13():830022. PubMed ID: 35574015
[TBL] [Abstract][Full Text] [Related]
18. Fgf21 is required for cardiac remodeling in pregnancy.
Redondo-Angulo I; Mas-Stachurska A; Sitges M; Tinahones FJ; Giralt M; Villarroya F; Planavila A
Cardiovasc Res; 2017 Nov; 113(13):1574-1584. PubMed ID: 28472473
[TBL] [Abstract][Full Text] [Related]
19. Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.
Alisi A; Ceccarelli S; Panera N; Prono F; Petrini S; De Stefanis C; Pezzullo M; Tozzi A; Villani A; Bedogni G; Nobili V
PLoS One; 2013; 8(6):e67160. PubMed ID: 23840612
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.
Degirolamo C; Sabbà C; Moschetta A
Nat Rev Drug Discov; 2016 Jan; 15(1):51-69. PubMed ID: 26567701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
